Alexza Pharms Drug Patent Portfolio
Alexza Pharms owns 1 orange book drug protected by 18 US patents Given below is the list of Alexza Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8387612 | Self-contained heating unit and drug-supply unit employing same | 23 Oct, 2026 | Active |
| US7537009 | Method of forming an aerosol for inhalation delivery | 28 Oct, 2024 | Expired |
| US7458374 | Method and apparatus for vaporizing a compound | 18 Aug, 2024 | Expired |
| US8991387 | Self-contained heating unit and drug-supply unit employing same | 21 May, 2024 | Expired |
| US9370629 | Self-contained heating unit and drug-supply unit employing same | 20 May, 2024 | Expired |
| US6716416 | Delivery of antipsychotics through an inhalation route | 20 May, 2022 | Expired |
| US7052679 | Delivery of antipsychotics through an inhalation route | 20 Mar, 2022 | Expired |
| US7078020 | Delivery of antipsychotics through an inhalation route | 26 Oct, 2021 | Expired |
| US7090830 | Drug condensation aerosols and kits | 26 Oct, 2021 | Expired |
| US7585493 | Thin-film drug delivery article and method of use | 26 Oct, 2021 | Expired |
| US7601337 | Delivery of antipsychotics through an inhalation route | 26 Oct, 2021 | Expired |
| US8074644 | Method of forming an aerosol for inhalation delivery | 26 Oct, 2021 | Expired |
| US8173107 | Delivery of antipsychotics through an inhalation route | 26 Oct, 2021 | Expired |
| US8235037 | Drug condensation aerosols and kits | 26 Oct, 2021 | Expired |
| US8955512 | Method of forming an aerosol for inhalation delivery | 26 Oct, 2021 | Expired |
| US9439907 | Method of forming an aerosol for inhalation delivery | 26 Oct, 2021 | Expired |
| US9440034 | Drug condensation aerosols and kits | 26 Oct, 2021 | Expired |
| US9687487 | Aerosol forming device for use in inhalation therapy | 26 Oct, 2021 | Expired |
Latest Legal Activities on Alexza Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Alexza Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 10 Jun, 2024 | US8173107 |
|
Maintenance Fee Reminder Mailed
Critical
| 06 May, 2024 | US9439907 |
|
Maintenance Fee Reminder Mailed
Critical
| 06 May, 2024 | US9440034 |
|
Maintenance Fee Reminder Mailed
Critical
| 25 Mar, 2024 | US8235037 |
|
Expire Patent
Critical
| 15 Jan, 2024 | US8074644 |
|
Maintenance Fee Reminder Mailed
Critical
| 25 Dec, 2023 | US8173107 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Dec, 2023 | US9370629 |
|
Maintenance Fee Reminder Mailed
Critical
| 31 Jul, 2023 | US8074644 |
|
Expire Patent
Critical
| 27 Mar, 2023 | US8955512 |
|
Maintenance Fee Reminder Mailed
Critical
| 10 Oct, 2022 | US8955512 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Sep, 2022 | US8991387 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Apr, 2021 | US7601337 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Mar, 2021 | US7585493 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Dec, 2020 | US9687487 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Nov, 2020 | US7537009 |
Alexza Pharms's Family Patents
Alexza Pharms drugs have patent protection in a total of 20 countries. It has a significant patent presence in the US with 51.9% of its patents being US patents. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Alexza Pharms Drug List
Given below is the complete list of Alexza Pharms's drugs and the patents protecting them.
1. Adasuve
Adasuve is protected by 18 patents, out of which 17 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8387612 | Self-contained heating unit and drug-supply unit employing same |
23 Oct, 2026
(1 year, 10 months from now)
| Active |
| US7537009 | Method of forming an aerosol for inhalation delivery |
28 Oct, 2024
(a month ago)
| Expired |
| US7458374 | Method and apparatus for vaporizing a compound |
18 Aug, 2024
(4 months ago)
| Expired |
| US8991387 | Self-contained heating unit and drug-supply unit employing same |
21 May, 2024
(6 months ago)
| Expired |
| US9370629 | Self-contained heating unit and drug-supply unit employing same |
20 May, 2024
(6 months ago)
| Expired |
| US6716416 | Delivery of antipsychotics through an inhalation route |
20 May, 2022
(2 years ago)
| Expired |
| US7052679 | Delivery of antipsychotics through an inhalation route |
20 Mar, 2022
(2 years ago)
| Expired |
| US7078020 | Delivery of antipsychotics through an inhalation route |
26 Oct, 2021
(3 years ago)
| Expired |
| US7090830 | Drug condensation aerosols and kits |
26 Oct, 2021
(3 years ago)
| Expired |
| US7585493 | Thin-film drug delivery article and method of use |
26 Oct, 2021
(3 years ago)
| Expired |
| US7601337 | Delivery of antipsychotics through an inhalation route |
26 Oct, 2021
(3 years ago)
| Expired |
| US8074644 | Method of forming an aerosol for inhalation delivery |
26 Oct, 2021
(3 years ago)
| Expired |
| US8173107 | Delivery of antipsychotics through an inhalation route |
26 Oct, 2021
(3 years ago)
| Expired |
| US8235037 | Drug condensation aerosols and kits |
26 Oct, 2021
(3 years ago)
| Expired |
| US8955512 | Method of forming an aerosol for inhalation delivery |
26 Oct, 2021
(3 years ago)
| Expired |
| US9439907 | Method of forming an aerosol for inhalation delivery |
26 Oct, 2021
(3 years ago)
| Expired |
| US9440034 | Drug condensation aerosols and kits |
26 Oct, 2021
(3 years ago)
| Expired |
| US9687487 | Aerosol forming device for use in inhalation therapy |
26 Oct, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adasuve's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List